{"id":{"repo_id":"mcmaster","oai_identifier":"oai:macsphere.mcmaster.ca:11375/33632"},"canonical_url":"https://search.ndltd.org/etd/mcmaster/oai:macsphere.mcmaster.ca:11375/33632","repository":{"repo_id":"mcmaster","name":"McMaster University","base_url":"https://macsphere.mcmaster.ca/server/oai/request"},"display":{"title":"Atrial Fibrillation and Heart Failure: Temporal Relationship, Subclinical Progression and Risk Factors","abstract":"Introduction Atrial fibrillation (AF) and heart failure (HF) are closely interconnected conditions that share common risk factors and frequently coexist. Subclinical AF (SCAF), typically asymptomatic AF detected only through long-term rhythm monitoring, represents an early stage in the AF continuum and is increasingly recognized as clinically important. However, its progression, temporal relationship with HF, prevalence in acute HF, and broader clinical significance remain incompletely understood. Aims/Methods The overarching aim of this thesis was to advance understanding of the relationship between AF and HF by examining the prognostic significance of SCAF progression, the temporal association between SCAF and HF, the prevalence and clinical significance of SCAF in acute HF, and the determinants of developing both AF and HF at the population level. Results In Chapters 2 and 3, data from ASSERT was used to evaluate the impact of SCAF progression and the temporal association between SCAF burden and HF events. Progression of SCAF to longer episode durations was independently associated with an increased risk of subsequent HF hospitalization, and clinical predictors of progression were identified. SCAF more often preceded HF events than followed them, with higher AF burden associated with greater short-term HF risk. In Chapter 4, the multicentre, prospective PROTECT-HF study evaluated the prevalence and role of SCAF after hospitalization for acute HF in patients with no prior history of AF. Systematic rhythm monitoring identified a non-trivial burden of previously unrecognized SCAF, which was associated with adverse prognosis, particularly mortality and progression to clinical AF. In Chapter 5, population-based studies identified clinical characteristics and cardiovascular risk factors associated with the future development of both AF and HF in the community. Conclusions This thesis clarifies the timing, progression, and prognostic significance of SCAF, advances understanding of the AF-HF relationship, and identifies SCAF as a potential early target for risk stratification and prevention.","abstract_html":"Introduction Atrial fibrillation (AF) and heart failure (HF) are closely interconnected conditions that share common risk factors and frequently coexist. Subclinical AF (SCAF), typically asymptomatic AF detected only through long-term rhythm monitoring, represents an early stage in the AF continuum and is increasingly recognized as clinically important. However, its progression, temporal relationship with HF, prevalence in acute HF, and broader clinical significance remain incompletely understood. Aims/Methods The overarching aim of this thesis was to advance understanding of the relationship between AF and HF by examining the prognostic significance of SCAF progression, the temporal association between SCAF and HF, the prevalence and clinical significance of SCAF in acute HF, and the determinants of developing both AF and HF at the population level. Results In Chapters 2 and 3, data from ASSERT was used to evaluate the impact of SCAF progression and the temporal association between SCAF burden and HF events. Progression of SCAF to longer episode durations was independently associated with an increased risk of subsequent HF hospitalization, and clinical predictors of progression were identified. SCAF more often preceded HF events than followed them, with higher AF burden associated with greater short-term HF risk. In Chapter 4, the multicentre, prospective PROTECT-HF study evaluated the prevalence and role of SCAF after hospitalization for acute HF in patients with no prior history of AF. Systematic rhythm monitoring identified a non-trivial burden of previously unrecognized SCAF, which was associated with adverse prognosis, particularly mortality and progression to clinical AF. In Chapter 5, population-based studies identified clinical characteristics and cardiovascular risk factors associated with the future development of both AF and HF in the community. Conclusions This thesis clarifies the timing, progression, and prognostic significance of SCAF, advances understanding of the AF-HF relationship, and identifies SCAF as a potential early target for risk stratification and prevention.","abstract_has_math":false,"creators":["Wong, Jorge Alfredo Saiyon"],"institution":null,"degree_name":null,"degree_level":null,"degree_discipline":null,"degree_department":"Health Research Methodology","school":null,"contributors":[],"advisors":["Devereaux, PJ"],"committee_chairs":[],"committee_members":[],"year":2026,"date_issued":"2026","date_published":"2026","updated_at":"2026-11-18T19:32:00Z","subjects":["MEDICINE::Dermatology and venerology,clinical genetics, internal medicine::Internal medicine::Cardiology"],"languages":["en"],"rights":["Attribution-NonCommercial-NoDerivs 2.5 Canada"],"rights_urls":["http://creativecommons.org/licenses/by-nc-nd/2.5/ca/"],"identifier_entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["https://doi.org/10.71548/25402"],"render_values":[{"text":"https://doi.org/10.71548/25402","href":"https://doi.org/10.71548/25402","code":true}]}],"person_identifier_entries":[]},"links":{"outbound_url":"https://hdl.handle.net/11375/33632","outbound_label":"Handle","outbound_source":"dc:identifier.uri","record_url":"https://hdl.handle.net/11375/33632","record_label":"Repository record","record_kind":"handle","record_source":"dc:identifier.uri","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://macsphere.mcmaster.ca/server/oai/request?verb=GetRecord&metadataPrefix=dim&identifier=oai%3Amacsphere.mcmaster.ca%3A11375%2F33632","prefix":"dim"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.advisor","label":"Advisor","values":["Devereaux, PJ"]},{"key":"dc:contributor.department","label":"Department","values":["Health Research Methodology"]},{"key":"dc:creator","label":"Author","values":["Wong, Jorge Alfredo Saiyon"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.accessioned","label":"Dc Date Accessioned","values":["2026-09-30T18:35:44Z"]},{"key":"dc:date.issued","label":"Date","values":["2026"]},{"key":"dc:type","label":"Dc Type","values":["Thesis"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["MEDICINE::Dermatology and venerology,clinical genetics, internal medicine::Internal medicine::Cardiology"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language.iso","label":"Language (ISO)","values":["en"]},{"key":"dc:rights","label":"Dc Rights","values":["Attribution-NonCommercial-NoDerivs 2.5 Canada"]},{"key":"dc:rights.uri","label":"Rights URI","values":["http://creativecommons.org/licenses/by-nc-nd/2.5/ca/"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["https://hdl.handle.net/11375/33632","https://doi.org/10.71548/25402"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["Introduction Atrial fibrillation (AF) and heart failure (HF) are closely interconnected conditions that share common risk factors and frequently coexist. Subclinical AF (SCAF), typically asymptomatic AF detected only through long-term rhythm monitoring, represents an early stage in the AF continuum and is increasingly recognized as clinically important. However, its progression, temporal relationship with HF, prevalence in acute HF, and broader clinical significance remain incompletely understood. Aims/Methods The overarching aim of this thesis was to advance understanding of the relationship between AF and HF by examining the prognostic significance of SCAF progression, the temporal association between SCAF and HF, the prevalence and clinical significance of SCAF in acute HF, and the determinants of developing both AF and HF at the population level. Results In Chapters 2 and 3, data from ASSERT was used to evaluate the impact of SCAF progression and the temporal association between SCAF burden and HF events. Progression of SCAF to longer episode durations was independently associated with an increased risk of subsequent HF hospitalization, and clinical predictors of progression were identified. SCAF more often preceded HF events than followed them, with higher AF burden associated with greater short-term HF risk. In Chapter 4, the multicentre, prospective PROTECT-HF study evaluated the prevalence and role of SCAF after hospitalization for acute HF in patients with no prior history of AF. Systematic rhythm monitoring identified a non-trivial burden of previously unrecognized SCAF, which was associated with adverse prognosis, particularly mortality and progression to clinical AF. In Chapter 5, population-based studies identified clinical characteristics and cardiovascular risk factors associated with the future development of both AF and HF in the community. Conclusions This thesis clarifies the timing, progression, and prognostic significance of SCAF, advances understanding of the AF-HF relationship, and identifies SCAF as a potential early target for risk stratification and prevention."]},{"key":"dc:description.degree","label":"Dc Description Degree","values":["Doctor of Philosophy (PhD)"]},{"key":"dc:title","label":"Title","values":["Atrial Fibrillation and Heart Failure: Temporal Relationship, Subclinical Progression and Risk Factors"]},{"key":"others:access_status","label":"Others Access Status","values":["embargo"]}]}],"canonical_facts":{"dc:contributor.advisor":["Devereaux, PJ"],"dc:contributor.department":["Health Research Methodology"],"dc:creator":["Wong, Jorge Alfredo Saiyon"],"dc:date.accessioned":["2026-09-30T18:35:44Z"],"dc:date.issued":["2026"],"dc:description.abstract":["Introduction Atrial fibrillation (AF) and heart failure (HF) are closely interconnected conditions that share common risk factors and frequently coexist. Subclinical AF (SCAF), typically asymptomatic AF detected only through long-term rhythm monitoring, represents an early stage in the AF continuum and is increasingly recognized as clinically important. However, its progression, temporal relationship with HF, prevalence in acute HF, and broader clinical significance remain incompletely understood. Aims/Methods The overarching aim of this thesis was to advance understanding of the relationship between AF and HF by examining the prognostic significance of SCAF progression, the temporal association between SCAF and HF, the prevalence and clinical significance of SCAF in acute HF, and the determinants of developing both AF and HF at the population level. Results In Chapters 2 and 3, data from ASSERT was used to evaluate the impact of SCAF progression and the temporal association between SCAF burden and HF events. Progression of SCAF to longer episode durations was independently associated with an increased risk of subsequent HF hospitalization, and clinical predictors of progression were identified. SCAF more often preceded HF events than followed them, with higher AF burden associated with greater short-term HF risk. In Chapter 4, the multicentre, prospective PROTECT-HF study evaluated the prevalence and role of SCAF after hospitalization for acute HF in patients with no prior history of AF. Systematic rhythm monitoring identified a non-trivial burden of previously unrecognized SCAF, which was associated with adverse prognosis, particularly mortality and progression to clinical AF. In Chapter 5, population-based studies identified clinical characteristics and cardiovascular risk factors associated with the future development of both AF and HF in the community. Conclusions This thesis clarifies the timing, progression, and prognostic significance of SCAF, advances understanding of the AF-HF relationship, and identifies SCAF as a potential early target for risk stratification and prevention."],"dc:description.degree":["Doctor of Philosophy (PhD)"],"dc:identifier.uri":["https://hdl.handle.net/11375/33632","https://doi.org/10.71548/25402"],"dc:language.iso":["en"],"dc:rights":["Attribution-NonCommercial-NoDerivs 2.5 Canada"],"dc:rights.uri":["http://creativecommons.org/licenses/by-nc-nd/2.5/ca/"],"dc:subject":["MEDICINE::Dermatology and venerology,clinical genetics, internal medicine::Internal medicine::Cardiology"],"dc:title":["Atrial Fibrillation and Heart Failure: Temporal Relationship, Subclinical Progression and Risk Factors"],"dc:type":["Thesis"],"others:access_status":["embargo"]},"updated_at":"2026-11-18T19:32:00Z"}